Us Bancorp \De\ Bicycle Therapeutics PLC Transaction History

Us Bancorp \De\

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 07, 2024	BUY	$16.75 - $26.1 $5,025 - $7,830	300 New	300 $7,000
Q3 2022 Oct 27, 2022	SELL	$17.49 - $28.44 $2,606 - $4,237	-149 Reduced 38.9%	234 $5,000
Q2 2022 Aug 01, 2022	BUY	$12.95 - $46.99 $1,929 - $7,001	149 Added 63.68%	383 $6,000
Q1 2022 May 11, 2022	SELL	$40.12 - $59.5 $5,496 - $8,151	-137 Reduced 36.93%	234 $10,000
Q4 2021 Feb 11, 2022	SELL	$41.7 - $61.14 $401,070 - $588,044	-9,618 Reduced 96.29%	371 $23,000
Q3 2021 Nov 10, 2021	SELL	$27.95 - $44.24 $76,918 - $121,748	-2,752 Reduced 21.6%	9,989 $416,000
Q2 2021 Aug 05, 2021	BUY	$27.0 - $32.28 $4,509 - $5,390	167 Added 1.33%	12,741 $387,000
Q1 2021 Apr 28, 2021	SELL	$19.12 - $30.25 $9,540 - $15,094	-499 Reduced 3.82%	12,574 $376,000
Q4 2020 Feb 04, 2021	BUY	$17.95 - $21.36 $234,660 - $279,239	13,073 New	13,073 $235,000

111

40.8M

39.6K

24.6K

Ticker BCYC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,676,100
Market Cap $433M
Description
Bicycle Therapeutics plc, a clinical-stage biopharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics. Its lead product candidate is BT1718, a bicycle toxin conjugate (BTC), which is in Phase I/IIa clinical trials targeting tumors that express Membrane Type 1 matrix metalloprotease. The co...

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

Stay updated on Us Bancorp \De\ with notifications on news.